WCLC 2022 Conference Coverage
Playback speed
10 seconds
WCLC 2022 on the Single Arm Phase II Study PEMMELA: Pembrolizumab + Lenvatinib in 2L/3L Malignant Pleural Mesothelioma Patients
By
WCLC 2022 Conference Coverage
FEATURING
Li-Anne Huaqing Douma
By
WCLC 2022 Conference Coverage
FEATURING
Li-Anne Huaqing Douma
21 views
August 18, 2022
Comments 0
Login to view comments.
Click here to Login
Videos